M&A Deal Summary |
|
---|---|
Date | 2016-08-01 |
Target | Accutron |
Sector | Medical Products |
Buyer(s) | Cantel Medical |
Deal Type | Add-on Acquisition |
Deal Value | 53M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1963 |
Sector | Medical Products |
Revenue | 1.0B USD (2020) |
Cantel Medical Corp. is a provider of medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Cantel Medical was formed in 1963 and is based in Little Falls, New Jersey.
DEAL STATS | # |
---|---|
Overall | 12 of 20 |
Sector (Medical Products) | 9 of 15 |
Type (Add-on Acquisition) | 10 of 15 |
State (Connecticut) | 1 of 1 |
Country (United States) | 8 of 11 |
Year (2016) | 2 of 3 |
Size (of disclosed) | 7 of 15 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-02-03 |
NAMSA - Sterility Assurance Monitoring Products Division
United States NAMSA - Sterility Assurance Monitoring Products Division is a manufacturer of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. Its domestic and international market segments include pharmaceutical, medical device, contract sterilizers, laboratories, health care, dental, food and beverage, and biotech companies. |
Buy | $14M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-09-26 |
Vantage Endoscopy - Endoscopy Assets
Kitchener, Ontario, Canada Vantage Endoscopy, Inc. - Endoscopy Assets is a provider of medical products. |
Buy | - |